Cognition Therapeutics, Inc.
CGTX
$0.3724
-$0.0008-0.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 21.08% | -41.13% | 23.06% | -12.41% | -20.63% |
| Total Depreciation and Amortization | 1.43% | 4.48% | 15.52% | -12.12% | 1.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.40% | -21.88% | -16.03% | 27.54% | 0.00% |
| Change in Net Operating Assets | -154.01% | 1,347.06% | -135.20% | -68.80% | 6.61% |
| Cash from Operations | -22.35% | -14.24% | 17.21% | -32.77% | -31.12% |
| Capital Expenditure | -- | 100.00% | -- | -- | 48.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | 48.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.41% | -2.21% | -1.69% | 0.56% | 16.74% |
| Issuance of Common Stock | 2,410.70% | 690.77% | -99.47% | 368.95% | 1,134.91% |
| Repurchase of Common Stock | -- | 100.00% | 79.25% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,359.27% | 338.41% | -101.15% | 391.72% | 81,400.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.97% | -6.26% | -229.25% | 255.86% | 27.81% |